A pilot study on the neurocognitive effect of sorafenib on patients with desmoid tumours: the SORA-COG study
This is the first study to examine the neurocognitive effects of sorafenib in patients with DT. We exhibit significantly higher anxiety in patients with DT on sorafenib as compared to healthy controls. There was a significant correlation noted between anxiety and treatment duration. We propose further longitudinal studies to assess the effect of sorafenib in DT.
Authors
- Ratna Sharma (ORCID: https://orcid.org/0000-0001-6810-3514)
- Ghazal Tansir (ORCID: https://orcid.org/0000-0002-1045-7771)
- Sameer Rastogi (ORCID: https://orcid.org/0000-0003-4792-3083)
- Sharanya Krishnakumar (ORCID: https://orcid.org/0000-0002-4061-7342)
- Simran Kaur (ORCID: https://orcid.org/0000-0001-9091-9480)
- Lulu Abdul Khader
- Fathima Shahama Oliyath Vazhayil
- Vaishnavi Vishwas
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2025-03-13
- DOI
- https://doi.org/10.3332/ecancer.2025.1871
- Citations
- 1
- Primary Topic
- Soft tissue tumor case studies
- Type
- article
- Field-Weighted Citation Impact
- 1.67